Zijing Jia

CAS Key Laboratory Of Infection And Immunity
Beijing, 100101, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron.

Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron.

Journal: Cell
Published: November 25, 2025

Author Correction: Establishing a universal IVRP method for quadrivalent HPV vaccines to replace in vivo potency tests.

Author Correction: Establishing a universal IVRP method for quadrivalent HPV vaccines to replace in vivo potency tests.

Journal: NPJ vaccines
Published: May 12, 2025

Overcoming drug resistance through extracellular vesicle-based drug delivery system in cancer treatment.

Overcoming drug resistance through extracellular vesicle-based drug delivery system in cancer treatment.

Journal: Cancer drug resistance (Alhambra, Calif.)
Published: August 10, 2024

Establishing a universal IVRP method for quadrivalent HPV vaccines to replace in vivo potency tests.

Establishing a universal IVRP method for quadrivalent HPV vaccines to replace in vivo potency tests.

Journal: NPJ vaccines
Published: March 17, 2024

A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2.

A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2.

Journal: Protein & cell
Published: February 29, 2024

Author Correction: A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD.

Author Correction: A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD.

Journal: Cell discovery
Published: December 08, 2023

Comparing T- and B-cell responses to COVID-19 vaccines across varied immune backgrounds.

Comparing T- and B-cell responses to COVID-19 vaccines across varied immune backgrounds.

Journal: Signal transduction and targeted therapy
Published: February 01, 2023

Development of neutralizing antibodies against SARS-CoV-2, using a high-throughput single-B-cell cloning method.

Development of neutralizing antibodies against SARS-CoV-2, using a high-throughput single-B-cell cloning method.

Journal: Antibody therapeutics
Published: November 15, 2022

Sequential immunizations confer cross-protection against variants of SARS-CoV-2, including Omicron in Rhesus macaques.

Sequential immunizations confer cross-protection against variants of SARS-CoV-2, including Omicron in Rhesus macaques.

Journal: Signal transduction and targeted therapy
Published: February 16, 2022

Selection and structural bases of potent broadly neutralizing antibodies from 3-dose vaccinees that are highly effective against diverse SARS-CoV-2 variants, including Omicron sublineages.

Selection and structural bases of potent broadly neutralizing antibodies from 3-dose vaccinees that are highly effective against diverse SARS-CoV-2 variants, including Omicron sublineages.

Journal: Cell research
Published: February 08, 2022

A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD.

A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD.

Journal: Cell discovery
Published: February 04, 2022

Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron.

Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron.

Journal: Cell
Published: December 28, 2021
Showing 1-12 of 16

Last Updated: 09/26/2026